Autoimmune & ArthritisNew IgG4 Guidelines Update Treatment Advice but Expose Evidence Gaps
New international guidelines update treatment guidance for IgG4-related disease, a chronic immune condition that can affect multiple organs and cause masses resembling tumors. A group of 62 contributors, including physicians, patients, a caregiver, and a librarian, developed 28 treatment statements after a systematic literature search. Physicians reached the required agreement threshold on 22 statements. Two recent phase 3 trials strengthened the evidence available since the previous international consensus statement in 2015, but most statements still relied on low-level evidence. The practical takeaway is to distinguish recommendations backed by clinical trials from those based mainly on expert judgment. This summary uses only the abstract, which does not list specific treatments, doses, benefits, or risks. It cannot establish which therapy is best for an individual patient.